Persistent primary thunderclap headache responsive to gabapentin by unknown
J Headache Pain (2006) 7:419–421
DOI 10.1007/s10194-006-0346-7
Persistent primary thunderclap headache
responsive to gabapentin
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Abstract We report the case of a
woman with an apparent primary
thunderclap headache which
occurred frequently until she
achieved a therapeutic dosage of
gabapentin. Primary thunderclap
headache is a rare type of headache
that warrants significant testing to
rule out more ominous possibilities.
Whether gabapentin may help other
primary thunderclap headache suf-
ferers or not remains unclear.
Further research is needed.
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Thunderclap headache (TCH) refers to an excruciating
headache of instantaneous onset. Multiple life-threatening
conditions may present this way. In the absence of these,
however, TCH may occur as a benign idiopathic headache
disorder, currently termed “primary thunderclap headache”
(PTCH). The International Classification of Headache
Disorders 2nd Edition diagnostic criteria for PTCH consist
of a severe head pain of sudden onset, reaching maximum
intensity in <1 min lasting from 1 h to 10 days; does not
recur regularly over subsequent weeks or months; and is
not attributed to another disorder [1]. Somewhat in con-
tradistinction to these criteria, in up to one third of
patients, PTCH may persist beyond 10 days or recur over
subsequent months to years, heavily impacting quality of
life [2]. Evidence for effective symptomatic treatment in
this setting is limited.
Case
A 49-year-old woman without prior headache history
presented to the emergency department with a severe
headache. At onset, upon clearing her throat, she felt a
“snap” inside her head followed immediately by a sud-
den, extremely severe, bilateral temporal-parietal throb-
bing headache. Her pain reached a severe intensity
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(10/10) within 5 s, and remained present for 3 h. She
continuously paced and screamed. Three hours after
onset, the severity came down to 8/10, and continued for
12 more hours after which the pain had a sudden offset.
Nausea, vomiting, autonomic features, focal neurologic
deficits and hypersensitivity to light, sound or smells
were absent. General and neurologic exams were nor-
mal. Brain computed tomography (CT), chest X-ray,
complete blood count, blood chemistry and lumbar
puncture were all normal. Cerebrospinal fluid (CSF)
revealed glucose 62 mg/dl, protein 27 mg/dl, 2 white
blood cells, 128 red blood cells in first tube (14 in sec-
ond) and no xanthochromia. Routine CSF cultures were
normal. Hydromorphine and metoclopramide failed to
provide relief.
Nine days before headache onset, she had a presumed
viral upper respiratory infection while travelling through
France. After the initial attack (day 1) she developed oth-
ers, nearly everyday for 11 days. Attacks were stereotypic
with “thunderclap” onset. Frequency was 1–3 a day, last-
ing 4–17 h each. An orthostatic component or time pattern
were absent. Events occurred spontaneously, or were trig-
gered by sitting or clearing her throat. On day 6, brain
magnetic resonance image (MRI) and magnetic resonance
angiography (MRA) were normal. On day 9, a neck
MRI/MRA ruled out a dissection and rizatriptan failed to
give analgesia.
On day 9, for unclear reasons, her local doctor started
gabapentin 300 mg and increased it by 300 mg a day to a
goal of 600 mg three times a day (reached by day 14). Her
last prolonged TCH occurred on day 12. She then experi-
enced a “crawling and soreness” sensation in her left pari-
etal region half of the day, and a brief daily headache, 60
s each. These resolved without additional treatment other
than the daily gabapentin and were identical to the origi-
nal headaches except for the duration. On day 38 (our
evaluation) her symptoms had not changed since day 12.
Since day 44, her “crawling and soreness” had disap-
peared, and she was only experiencing one 60-s event
every 3 days. She was still on gabapentin 1800 mg/day
secondary to concerns for recurrence of the prolonged
attacks as they had been so torturous.
Discussion
TCH refers to an excruciating headache of instantaneous
onset – as sudden and as unexpected as a “clap of thunder”
[3]. This term was first utilised to describe this type of
headache as a presentation of an unruptured cerebral
aneurysm, but a number of secondary causes are well
known to present with TCH including subarachnoid
haemorrhage, cerebral venous sinus thrombosis (CVST),
pituitary apoplexy, spontaneous intracranial hypotension
(SIH), hypertensive encephalopathy, obstructive hydro-
cephalus, carotid artery dissection and retroclival
haematomas [2, 4]. Although an association between the
Erve virus and TCH has been suggested, a causative link
has not been proven [5].
In the absence of secondary causes, TCH may occur as
a benign idiopathic headache disorder, currently termed
“PTCH” [1]. Because of the profound morbidity of most
of the secondary causes of TCH, the diagnosis of PTCH is
one of exclusion. A brain CT is obligatory to rule out a
subarachnoid haemorrhage and, when negative, a CSF
analysis including xanthochromia is required [2]. When
initial CT and CSF examinations are normal, clinical
judgement guides further investigations [2].
The absent xanthochromia and clearing of our
patient’s CSF suggests a traumatic puncture as the cause
of increased red blood cells. At the time of our evaluation,
her prior tests had ruled out most, but not all, of the sinis-
ter conditions that can cause TCH. Hyperelastic joints and
skin, pachymeningeal gadolinium enhancement, and
“brain sag” on MRI, all of which could suggest SIH, were
absent [6]. A brain magnetic resonance venogram (MRV)
showed no evidence of CVST.
Migraine attacks occasionally have an abrupt onset
(“crash migraine”), mimicking PTCH [7]. Although the
distinction between these can be difficult, in the absence
of nausea, vomiting, photophobia and phonophobia,
migraine is an inadequate explanation [1].
Little is known about the symptomatic treatment of
PTCH. Oral and intravenous nimodipine may be effective
[8]. A long-term follow-up of patients with recurrent
PTCH showed that individuals had substantial impairment
in their working capacity and social functioning [9]. Our
patient’s response to gabapentin was dramatic and impres-
sive during a time when headaches were still worsening,
suggesting medication effect more than the natural histo-
ry of a resolving entity. The exact mechanism of action
through which gabapentin decreases pain in headache is
not known but multiple mechanisms might be involved.
Gabapentin enhances GABA-mediated inhibition, inhibits
GABA metabolism and modulates L-type calcium chan-
nels by binding to its α′ 2δ subunit [10]. A limitation of our
report is that, unfortunately, we could not have our patient
stop gabapentin and evaluate her symptoms. However, in
the presence of known significant disability and in the
absence of effective treatment options associated with
PTCH, gabapentin may be a reasonable and successful
treatment for persistent PTCH. Further investigation is
clearly needed.
Intriguing is the fact that our patient developed her
headaches shortly after a presumed viral upper respiratory
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infection upon returning from western France, where the
natural focus of the Erve virus is thought to be located [5].
One can only speculate at this juncture about the potential
association of her headache with the Erve or another virus.
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